The A.I. story nobody is telling you (Read ASAP)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.

Michael Demurjian net worth and biography

Michael Demurjian Biography and Net Worth

Major Shareholder of Tyme Technologies

Michael Demurjian is the founder, chairman, and CEO of clinical-stage pharmaceutical company, Aspargo Laboratories, Inc.

Aspargo is the developer of an oral spray formulation that serves as an alternative to Viagra® and Cialis®.

In 2011, Demurjian also co-founded Tyme Technologies, Inc., a clinical-stage biotechnology company creating metabolic-based cancer therapeutics designed to be effective across tumor types. While there, Demurjian raised over $50 million and took Tyme public on NASDAQ, holding 70 percent control of the company with his partner, Steve Hoffman.

Prior to Aspargo Labs and Tyme, the biotech leader was CEO of oncology research firm, Luminant Biosciences. He has taken companies both public and private and raised funds via retail and institutional investors, including deals with G.E., Black & Decker Corp., Stryker, and Crane Cams.

Demurjian currently serves on the Susan G. Komen Foundation board of directors and New York University’s board of advisors. Previously, he sat on the boards of KCC Inc., Mikronite Technologies, and Luminant Biosciences.

What is Michael Demurjian's net worth?: The estimated net worth of Michael Demurjian is at least $7.05 million as of August 22nd, 2022. Mr. Demurjian owns 22,688,846 shares of Tyme Technologies stock worth more than $7,049,424 as of April 19th. This net worth approximation does not reflect any other assets that Mr. Demurjian may own. Learn More about Michael Demurjian's net worth.
How do I contact Michael Demurjian?: The corporate mailing address for Mr. Demurjian and other Tyme Technologies executives is 17 STATE STREET 7TH FLOOR, NEW YORK NY, 10004. Tyme Technologies can also be reached via phone at (212) 461-2315 and via email at [email protected]. Learn More on Michael Demurjian's contact information.
Has Michael Demurjian been buying or selling shares of Tyme Technologies?: Michael Demurjian has not been actively trading shares of Tyme Technologies over the course of the past ninety days. Most recently, Michael Demurjian sold 80,000 shares of the business's stock in a transaction on Monday, August 22nd. The shares were sold at an average price of $0.29, for a transaction totalling $23,200.00. Following the completion of the sale, the insider now directly owns 22,688,846 shares of the company's stock, valued at $6,579,765.34. Learn More on Michael Demurjian's trading history.
Who are Tyme Technologies' active insiders?: Tyme Technologies' insider roster includes James Biehl (Insider), David Carberry (Director), Michael Demurjian (Major Shareholder), Barbara Galaini (Insider), Steve Hoffman (Insider), and Jan Van Rornout (Insider). Learn More on Tyme Technologies' active insiders.

Michael Demurjian Insider Trading History at Tyme Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/22/2022	Sell	80,000	$0.29	$23,200.00	22,688,846
7/25/2022	Sell	70,000	$0.29	$20,300.00	22,838,846
7/11/2022	Sell	70,000	$0.29	$20,300.00	22,978,846
6/27/2022	Sell	60,000	$0.26	$15,600.00	23,108,846
6/14/2022	Sell	60,000	$0.25	$15,000.00	23,228,846
5/31/2022	Sell	53,097	$0.25	$13,274.25	23,355,749
5/16/2022	Sell	50,000	$0.25	$12,500.00	23,458,846
5/2/2022	Sell	50,000	$0.31	$15,500.00	23,558,846
4/19/2022	Sell	40,000	$0.32	$12,800.00	23,648,846
4/12/2022	Sell	20,000	$0.34	$6,800.00	23,688,846
4/4/2022	Sell	20,000	$0.35	$7,000.00	23,708,846
3/28/2022	Sell	20,000	$0.34	$6,800.00
3/21/2022	Sell	20,000	$0.33	$6,600.00
2/14/2022	Sell	20,000	$0.33	$6,600.00
2/7/2022	Sell	20,000	$0.36	$7,200.00
1/31/2022	Sell	20,000	$0.34	$6,800.00
1/24/2022	Sell	20,000	$0.52	$10,400.00
1/20/2022	Sell	320	$0.59	$188.80
1/3/2022	Sell	20,000	$0.64	$12,800.00
12/27/2021	Sell	20,000	$0.66	$13,200.00
12/21/2021	Sell	20,000	$0.70	$14,000.00
12/13/2021	Sell	20,000	$0.75	$15,000.00
12/7/2021	Sell	20,000	$0.73	$14,600.00
12/2/2021	Sell	20,000	$0.75	$15,000.00
11/22/2021	Sell	9,380	$0.80	$7,504.00
11/17/2021	Sell	20,000	$0.91	$18,200.00
11/8/2021	Sell	20,000	$1.00	$20,000.00
11/3/2021	Sell	20,000	$1.00	$20,000.00
10/29/2021	Sell	20,000	$0.95	$19,000.00
10/20/2021	Sell	20,000	$0.97	$19,400.00
10/13/2021	Sell	20,000	$1.00	$20,000.00
10/4/2021	Sell	20,000	$1.00	$20,000.00
9/27/2021	Sell	20,000	$1.12	$22,400.00
9/20/2021	Sell	20,000	$1.01	$20,200.00
9/13/2021	Sell	20,000	$1.04	$20,800.00	24,258,546
9/7/2021	Sell	20,000	$1.12	$22,400.00	24,278,546
8/30/2021	Sell	20,000	$1.10	$22,000.00	24,298,546
8/23/2021	Sell	20,000	$1.03	$20,600.00	24,318,546
8/16/2021	Sell	20,000	$1.02	$20,400.00	24,338,546
7/26/2021	Sell	20,000	$1.53	$30,600.00	24,398,546
7/19/2021	Sell	20,000	$1.02	$20,400.00	24,418,546
7/12/2021	Sell	20,000	$1.16	$23,200.00	24,438,546
7/6/2021	Sell	20,000	$1.18	$23,600.00
6/28/2021	Sell	20,000	$1.32	$26,400.00	24,478,546
6/21/2021	Sell	20,000	$1.26	$25,200.00	24,498,546
6/14/2021	Sell	20,000	$1.43	$28,600.00	24,518,546
6/7/2021	Sell	20,000	$1.61	$32,200.00	24,538,546
6/1/2021	Sell	20,000	$1.58	$31,600.00
5/24/2021	Sell	20,000	$1.35	$27,000.00	24,578,546
5/17/2021	Sell	20,000	$1.31	$26,200.00	24,598,546
5/11/2021	Sell	20,000	$1.23	$24,600.00	24,618,546
4/26/2021	Sell	20,000	$1.54	$30,800.00	24,658,546
4/19/2021	Sell	20,000	$1.45	$29,000.00	24,678,546
4/12/2021	Sell	20,000	$1.57	$31,400.00	24,698,546
4/5/2021	Sell	20,000	$1.78	$35,600.00	24,718,546
3/29/2021	Sell	20,000	$1.73	$34,600.00	24,738,546
3/22/2021	Sell	20,000	$2.07	$41,400.00	24,758,546
3/16/2021	Sell	20,000	$2.21	$44,200.00	24,778,546
3/8/2021	Sell	20,000	$1.85	$37,000.00	24,798,546
3/1/2021	Sell	20,000	$2.10	$42,000.00
2/16/2021	Sell	20,000	$2.77	$55,400.00	24,858,546
2/1/2021	Sell	20,000	$1.69	$33,800.00	24,898,546
1/25/2021	Sell	20,000	$2.07	$41,400.00	24,918,546
1/19/2021	Sell	20,000	$1.95	$39,000.00	24,938,546
1/11/2021	Sell	20,000	$1.62	$32,400.00	24,958,546
12/28/2020	Sell	20,000	$1.12	$22,400.00	24,998,546
12/21/2020	Sell	20,000	$1.15	$23,000.00	25,018,546
12/14/2020	Sell	20,000	$1.19	$23,800.00	25,038,546
12/7/2020	Sell	20,000	$1.07	$21,400.00	25,058,546
11/30/2020	Sell	20,000	$1.08	$21,600.00	25,078,546
11/23/2020	Sell	20,000	$0.93	$18,600.00	25,098,546
11/2/2020	Sell	20,000	$0.86	$17,200.00	25,158,546
10/19/2020	Sell	20,000	$1.03	$20,600.00	25,178,546
10/16/2020	Sell	20,000	$1.02	$20,400.00	25,198,546
10/7/2020	Sell	20,000	$1.00	$20,000.00	25,218,546
10/2/2020	Sell	20,000	$0.97	$19,400.00	25,238,546
9/21/2020	Sell	20,000	$0.98	$19,600.00	25,258,546
9/14/2020	Sell	20,000	$1.03	$20,600.00	25,278,546
9/8/2020	Sell	20,000	$1.02	$20,400.00	25,298,546
9/2/2020	Sell	20,000	$1.04	$20,800.00	25,318,546
8/24/2020	Sell	20,000	$1.17	$23,400.00	25,338,546
8/17/2020	Sell	20,000	$1.29	$25,800.00	25,358,546
8/10/2020	Sell	20,000	$1.30	$26,000.00
8/3/2020	Sell	20,000	$1.28	$25,600.00	25,398,546
7/27/2020	Sell	20,000	$1.22	$24,400.00	25,418,546
7/20/2020	Sell	20,000	$1.24	$24,800.00	25,438,546
7/13/2020	Sell	20,000	$1.20	$24,000.00	25,458,546
7/6/2020	Sell	20,000	$1.32	$26,400.00
6/22/2020	Sell	20,000	$1.36	$27,200.00	23,718,546
6/15/2020	Sell	20,000	$1.35	$27,000.00	23,738,546
6/8/2020	Sell	20,000	$1.53	$30,600.00	23,758,546
6/1/2020	Sell	20,000	$1.50	$30,000.00	23,778,546
5/26/2020	Sell	20,000	$1.62	$32,400.00	23,798,546
5/18/2020	Sell	20,000	$1.62	$32,400.00	23,818,546
5/11/2020	Sell	20,000	$1.40	$28,000.00	23,838,546
5/4/2020	Sell	20,000	$1.42	$28,400.00	23,858,546
4/27/2020	Sell	20,000	$1.16	$23,200.00	23,878,546
4/20/2020	Sell	20,000	$1.19	$23,800.00	23,898,546
4/13/2020	Sell	20,000	$1.23	$24,600.00	23,918,546
4/6/2020	Sell	20,000	$1.05	$21,000.00	23,938,546
3/30/2020	Sell	20,000	$1.05	$21,000.00	23,958,546
3/23/2020	Sell	20,000	$0.97	$19,400.00	24,005,617
3/20/2020	Sell	7,071	$1.03	$7,283.13	24,005,617
3/16/2020	Sell	4,904	$1.03	$5,051.12	24,005,617
2/10/2020	Sell	20,000	$1.34	$26,800.00	24,070,521
1/27/2020	Sell	20,000	$1.52	$30,400.00	25,010,521
1/21/2020	Sell	20,000	$1.90	$38,000.00	25,030,521
1/13/2020	Sell	20,000	$1.64	$32,800.00	25,050,521
1/6/2020	Sell	20,000	$1.47	$29,400.00	25,070,521
12/30/2019	Sell	20,000	$1.07	$21,400.00	25,090,521
12/23/2019	Sell	20,000	$0.97	$19,400.00	26,010,521
12/16/2019	Sell	20,000	$1.05	$21,000.00	26,030,521
12/9/2019	Sell	20,000	$1.08	$21,600.00	26,050,521
12/2/2019	Sell	20,000	$1.14	$22,800.00	26,070,521
11/25/2019	Sell	20,000	$1.13	$22,600.00	26,090,521
11/18/2019	Sell	20,000	$1.09	$21,800.00
11/11/2019	Sell	20,000	$1.16	$23,200.00	26,130,521
11/4/2019	Sell	20,000	$1.27	$25,400.00
10/28/2019	Sell	20,000	$1.36	$27,200.00
10/21/2019	Sell	20,000	$1.40	$28,000.00
10/14/2019	Sell	20,000	$92.98	$1,859,600.00
10/7/2019	Sell	20,000	$1.35	$27,000.00
10/1/2019	Sell	20,000	$1.42	$28,400.00
9/23/2019	Sell	20,000	$1.67	$33,400.00
9/16/2019	Sell	20,000	$1.58	$31,600.00
9/9/2019	Sell	20,000	$1.23	$24,600.00
9/3/2019	Sell	20,000	$1.14	$22,800.00	26,330,521
8/26/2019	Sell	20,000	$1.10	$22,000.00
8/19/2019	Sell	20,000	$1.03	$20,600.00
8/12/2019	Sell	20,000	$1.00	$20,000.00
8/5/2019	Sell	20,000	$1.12	$22,400.00
7/29/2019	Sell	50,000	$1.11	$55,500.00
7/22/2019	Sell	50,000	$1.18	$59,000.00
6/26/2018	Sell	141,134	$3.83	$540,543.22
6/19/2018	Sell	18,099	$3.75	$67,871.25
2/13/2018	Sell	400	$3.75	$1,500.00
12/11/2017	Sell	1,900	$3.73	$7,087.00
11/14/2017	Sell	50,000	$3.34	$167,000.00

Michael Demurjian Buying and Selling Activity at Tyme Technologies

Tyme Technologies Company Overview

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey.

Today's Range

Now: $0.31

$0.29

$0.32

50 Day Range

MA: $0.30

$0.24

$0.35

2 Week Range

Now: $0.31

$0.22

$1.14

Volume

2,678,186 shs

Average Volume

1,009,732 shs

Market Capitalization

$53.50 million

P/E Ratio

N/A

Dividend Yield